RxDoctor Payments Data

Stacy Jefferson, MD

Family Medicine · Saint Charles, MONPI 1720492028

Payments from drug & device makers

$2,346in general payments, 2019–2025

Across 141 payments — averaging $16.64 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$463
  • GSK$403
  • Novo Nordisk$330
  • AstraZeneca$295
  • AbbVie$188
  • Sanofi-aventis U.S. LLC$150
  • plus $515 from 14 others

What the payments were for

  • Food & beverage$2,346100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,346 in reported general payments places this provider in the 75th percentile of 2,203 family medicine providers in Missouri.

See all family medicine providers in Missouri

Medicare billing

Part B allowed, 2024
$19,509
Medicare patients
81
Services billed
257

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin73$87,862
MounjaroTirzepatide50$54,688
Trelegy ElliptaFluticasone/Umeclidin/Vilanter60$51,158
EliquisApixaban42$41,100
FarxigaDapagliflozin Propanediol46$39,292
OzempicSemaglutide37$37,640
XareltoRivaroxaban34$34,272
JanuviaSitagliptin Phosphate30$31,727
TrulicityDulaglutide18$23,260
TradjentaLinagliptin20$21,016
SymbicortBudesonide/Formoterol Fumarate30$8,909
Breo ElliptaFluticasone/Vilanterol17$6,537
Lantus SolostarInsulin Glargine,hum.Rec.Anlog40$6,215
ArexvyRsvpref3 Antigen/As01e/Pf18$5,222
Incruse ElliptaUmeclidinium Bromide13$4,638

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta$119$108,87993 claims
Lilly USA, LLCMounjaro, Trulicity$463$77,94868 claims
GSKTrelegy Ellipta, Breo Ellipta, Arexvy, Incruse Ellipta$403$67,555108 claims
AstraZenecaFarxiga, Symbicort$295$48,20176 claims
PfizerEliquis$81$41,10042 claims
Novo NordiskOzempic$330$37,64037 claims
Johnson & JohnsonXarelto$95$34,27234 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,203 family medicine providers in Missouri.

Other family medicine in Saint Charles

See the full list for Missouri

Where these figures come from

Is this you, or does something look wrong? →